BNTC Insider Trading

Insider Ownership Percentage: 1.57%
Insider Buying (Last 12 Months): $32,081.12
Insider Selling (Last 12 Months): $0.00

Benitec Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Benitec Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Benitec Biopharma Share Price & Price History

Current Price: $0.17
Price Change: +0.30 (1.20%)
As of 12/8/2022 01:00 AM ET

This chart shows the closing price history over time for BNTC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Benitec Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2021Steven Michael OliveiraMajor ShareholderBuy10,553$3.04$32,081.12View SEC Filing Icon  
11/29/2021Steven Michael OliveiraMajor ShareholderBuy37,947$3.18$120,671.46View SEC Filing Icon  
5/3/2021Steven Michael OliveiraMajor ShareholderBuy40,500$4.25$172,125.00View SEC Filing Icon  
4/30/2021Steven Michael OliveiraMajor ShareholderBuy120,000$4.18$501,600.00View SEC Filing Icon  
4/28/2021Steven Michael OliveiraMajor ShareholderBuy100,000$5.45$545,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Benitec Biopharma (NASDAQ:BNTC)

16.39% of Benitec Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BNTC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Benitec Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Empery Asset Management LP796,837$0.30M1.8%N/A2.848%Search for SEC Filing on Google Icon
11/15/2022Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC1,555,039$0.58M0.0%N/A6.025%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC120,429$45K0.0%N/A0.467%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP658,796$0.25M0.1%N/A2.552%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC25,132$29K0.0%N/A0.308%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC47,393$55K0.0%N/A0.580%Search for SEC Filing on Google Icon
5/13/2022Silverarc Capital Management LLC492,880$57K0.0%-16.1%6.031%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244%Search for SEC Filing on Google Icon
8/16/2021State Street Corp21,000$89K0.0%N/A0.267%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC42,700$0.18M0.0%N/A0.544%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp11,813$50K0.0%N/A0.150%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC34,493$0.15M0.0%+20.8%0.439%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.74,773$0.32M0.0%+43.3%0.952%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190%Search for SEC Filing on Google Icon
7/31/2021Private Wealth Advisors LLC15,043$64K0.0%N/A0.192%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC23,253$0.12M0.0%N/A0.483%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC22,520$0.12M0.0%+17.8%0.467%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC23,253$0.12M0.0%N/A0.483%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp17,653$91K0.0%N/A0.366%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC28,560$0.15M0.0%N/A0.593%Search for SEC Filing on Google Icon
4/14/2021WealthTrust Axiom LLC12,950$66K0.0%N/A0.269%Search for SEC Filing on Google Icon
4/12/2021HighPoint Advisor Group LLC93,000$0.46M0.1%N/A1.930%Search for SEC Filing on Google Icon
3/4/2021Hudson Bay Capital Management LP107,995$0.32M0.0%N/A2.241%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC19,114$57K0.0%N/A0.397%Search for SEC Filing on Google Icon
2/16/2021Warberg Asset Management LLC10,000$30K0.0%N/A0.903%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC50,660$0.15M0.0%N/A4.572%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley34,838$0.22M0.0%+18.7%3.144%Search for SEC Filing on Google Icon
8/14/2020Sabby Management LLC11,863$94K0.0%-45.1%1.108%Search for SEC Filing on Google Icon
5/15/2020Sabby Management LLC21,592$85K0.0%-81.7%2.016%Search for SEC Filing on Google Icon
5/15/2020Morgan Stanley28,690$0.11M0.0%+82.1%2.679%Search for SEC Filing on Google Icon
11/27/2019Sabby Management LLC1,365,615$0.97M0.5%N/A106.689%Search for SEC Filing on Google Icon
11/14/2018Sphera Funds Management LTD.120,000$0.29M0.0%N/A1.088%Search for SEC Filing on Google Icon
11/13/2018Highbridge Capital Management LLC273,010$0.65M0.0%-64.6%2.475%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Benitec Biopharma logo
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.
Read More on Benitec Biopharma

Today's Range

Now: $0.17
Low: $0.16
High: $0.18

50 Day Range

MA: $0.21
Low: $0.15
High: $0.37

52 Week Range

Now: $0.17
Low: $0.13
High: $3.30

Volume

131,909 shs

Average Volume

335,740 shs

Market Capitalization

$4.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of Benitec Biopharma?

Benitec Biopharma's top insider investors include:
  1. Steven Michael Oliveira (Major Shareholder)
Learn More about top insider investors at Benitec Biopharma.

Who are the major institutional investors of Benitec Biopharma?

Benitec Biopharma's top institutional shareholders include:
  1. Armistice Capital LLC — 6.02%
  2. Empery Asset Management LP — 2.85%
  3. Altium Capital Management LP — 2.55%
  4. Cantor Fitzgerald L. P. — 0.48%
  5. Renaissance Technologies LLC — 0.47%
  6. Group One Trading L.P. — 0.00%
Learn More about top institutional investors of Benitec Biopharma stock.

Which institutional investors are buying Benitec Biopharma stock?

Within the previous quarter, BNTC stock was bought by institutional investors including:
  1. Armistice Capital LLC
  2. Empery Asset Management LP
  3. Altium Capital Management LP
  4. Cantor Fitzgerald L. P.
  5. Renaissance Technologies LLC
  6. Group One Trading L.P.